- a Stanford Group analyst noted that an advisory panel met yesterday to discuss a potential 52% cut in the reimbursement for the insertion of leads for use with the device.

Other headlines for [CYBX]

• CYBX 11/21/2008 04:47am
  Cyberonics, Inc Piper Jaffray Raised CYBX to Buy from Neutral, price target: $15
  
• CYBX 11/19/2008 05:00pm
  Cyberonics, Inc Reports Q2 $0.14 v $0.06e, R $36M v $34.2Me- Guides FY09 Rev guidance $136-140M v $138.4Me - Q2 Gross Margin 85.6% v 84.2% q/q
  
• CYBX 10/31/2008 08:29am
  Cyberonics, Inc Reaffirms FY09 R$134-138M v $138.4Me
  
• CYBX 10/6/2008 09:01am
  Cyberonics, Inc Repurchases $12.7M of its 3% Convertible Notes
  

Healthcare sector headlines

• SVA Today 07:04am
  Sinovac Biotech Releases statement on Sinovac vaccine suspension- Health Services Bureau of Fengtai District in the City of Beijing suspended the use of 83 doses of inactivated hepatitis A vaccine Healive(R), more...
  
• NOVA Today 07:01am
  NovaMed Inc Acquires 65% stake in Physicians Surgical Center in Pennsylvania- Physicians Surgical Center has three operating rooms and one procedure room and currently performs orthopedic, ENT, ophthalmology, more...
  
• MITI Today 07:00am
  Micromet Expands committed equity financing facility to $75M from $25M- Under the terms of the agreement, Kingsbridge has committed to provide up to $75M of capital during the next three years through the more...
  
• MRX Today 06:54am
  Medicis Pharmaceutical Corp. Jefferies Raised MRX to Buy from Hold
  
• TTP Today 06:31am
  Tital Pharmaceuticals Plans to cut about 18 jobs (40% of workforce)- The Company’s remaining staff is focused on reducing all current clinical and manufacturing development activities to the minimal level necessary to more...